{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:31:49Z","timestamp":1790757109345,"version":"4.1.0"},"reference-count":110,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R13CA232383\u201001"],"award-info":[{"award-number":["1R13CA232383\u201001"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The 6th International Symposium on Childhood, Adolescent and Young Adult (<jats:styled-content style=\"fixed-case\">CAYA<\/jats:styled-content>) Non\u2010Hodgkin Lymphoma (<jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content>) was held in Rotterdam, Netherlands, 26\u201329 September, 2018. This summary manuscript is a perspective on the presentations from the plenary scientific sessions, including wellness and survivorship, B\u2010cell <jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> AYA<\/jats:styled-content> lymphoma, translational <jats:styled-content style=\"fixed-case\">NHL<\/jats:styled-content> biology, lymphoma immunology, bone marrow transplantation and cell therapy, T\/Natural Killer cell lymphoma, anaplastic large cell lymphoma, lymphoblastic lymphoma, novel lymphoma therapeutics and Hodgkin lymphoma. The symposium was attended by over 260 registrants from 42 different countries and included young, middle and senior investigators. Finally, the Angelo Rosolen, <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>, Memorial Lecture was delivered by Alfred Reiter, <jats:styled-content style=\"fixed-case\">MD<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/bjh.15764","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T02:06:21Z","timestamp":1549505181000},"page":"1021-1042","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Childhood, adolescent and young adult non\u2010Hodgkin lymphoma: current perspectives"],"prefix":"10.1111","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-434X","authenticated-orcid":false,"given":"Mitchell S.","family":"Cairo","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Medicine, Pathology, Microbiology&amp; Immunology, and Cell Biology &amp; Anatomy New York Medical College Valhalla NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auke","family":"Beishuizen","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haemato\u2010Oncology Princess Maxima Centre for Paediatric Oncology Utrecht The Netherlands"},{"name":"Department of Paediatric Oncology\/Haematology Erasmus MC \u2013 Sophia Children's Hospital Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/412163"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1387"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510795"},{"key":"e_1_2_13_6_1","first-page":"10","article-title":"Diagnosis and treatment of rare B\u2010NHL variants in children and adolescents","volume":"182","author":"Attarbaschi A.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23040"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.203"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31610-0"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20684"},{"key":"e_1_2_13_11_1","volume-title":"Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival, 1975\u20132000","author":"Bleyer W.A.","year":"2006"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-106021"},{"key":"e_1_2_13_13_1","doi-asserted-by":"crossref","unstructured":"Brugieres L.&Brice P.(2016)Lymphoma in adolescents and young adults. In: Tumors in Adolescents and Young Adults Progress in Tumor Research (ed. by D.P. Stark & G. Vassal) Vol. 43 pp. 101\u2013114. Karger Basel.","DOI":"10.1159\/000447080"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1487"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05735.x"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.3367"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14035"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15491"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-673236"},{"key":"e_1_2_13_20_1","first-page":"15","article-title":"Clinical features and treatment outcome of children with primary mediastinal large B\u2010cell lymphoma in Taiwan","volume":"182","author":"Chen S.\u2010H.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0855"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1318"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-066852"},{"key":"e_1_2_13_25_1","first-page":"30","article-title":"The anaplastic large cell lymphoma (ALCL)\u2010associated nucleophosmin\u2010anaplastic lymphom kinase (NPM\u2010ALK) directs expression of the nuclear protein brahma related gene 1 (BRG1) driving cell survival","volume":"182","author":"Ducray S.P.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_26_1","first-page":"5","article-title":"Childhood and adolescent non\u2010Hodgkin lymphoma survivorship: the childhood cancer survivor study (CCSS) and St. Jude lifetime (SJLIFE) cohorts","volume":"182","author":"Ehrhardt M.J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31019"},{"key":"e_1_2_13_28_1","first-page":"29","article-title":"Examining the function of PDGFRB in anaplastic large cell lymphoma","volume":"182","author":"los Fayos Alonso I.G.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_29_1","first-page":"13","article-title":"Epidemiology and outcome of adolescents and young adults with NHL and Hodgkin lymphoma","volume":"182","author":"Flower A.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15520"},{"key":"e_1_2_13_31_1","first-page":"23","article-title":"Safety and efficacy of myeloablative conditioning autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed\/refractory mature B\u2010cell non Hodgkin lymphoma","volume":"182","author":"Gardenswartz A.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.11.042"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13969"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.255"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13040"},{"key":"e_1_2_13_36_1","first-page":"11","article-title":"Reduced burden of oncologic therapy in children, adolescents and young adults with good risk (GR) CD20\u00a0+\u00a0 mature B\u2010cell lymphoma","volume":"182","author":"Goldman S.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_37_1","first-page":"14","article-title":"Novel targeted immunotherapy in newly diagnosed adolescent and young adults with Hodgkin lymphoma","volume":"182","author":"Hochberg J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_38_1","first-page":"8","article-title":"Long term follow up of pediatric lymphoma survivors upon entry into a wellness and survivorship program","volume":"182","author":"Hochberg J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27073"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30739"},{"key":"e_1_2_13_41_1","first-page":"12","article-title":"UCH\u2010L1 bypasses mTOR to promote protein biosynthesis and is required for MYC driven lymphomagenesis in mice","volume":"182","author":"Hussain S.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_42_1","first-page":"38","article-title":"Omipalisib (GSK458), a dual pan\u2010P13K\/mTOR inhibitor, exhibits in\u00a0vitro and in\u00a0vivo activity in chemotherapy\u2010sensitive and \u2010resistant models of Burkitt lymphoma","volume":"182","author":"Ippolito T.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2009.07.009"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.321"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.4"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3413"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.5246"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-756841"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.5411"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.139162"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011001)92:7<1959::AID-CNCR1715>3.0.CO;2-Y"},{"key":"e_1_2_13_52_1","first-page":"37","article-title":"Ruxolitinib significantly enhances in\u00a0vitro apoptosis in Hodgkin lymphoma (HL) and primary mediastinal B\u2010cell lymphoma (PMBL) and survival in a lymphoma xenograft murine mouse: an AYA therapeutic opportunity","volume":"182","author":"Levine S.R.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_53_1","first-page":"27","article-title":"Novel pathways of oncogenesis in anaplastic large cell lymphoma (ALCL)","volume":"182","author":"Lim M.S.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.04.012"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30153-4"},{"key":"e_1_2_13_56_1","first-page":"29","article-title":"Comprehensive characterization of plasma\u2010derived exosomes in anaplastic large cell lymphoma of childhood","volume":"182","author":"Lovisa F.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_57_1","first-page":"35","article-title":"Novel targets and outcome in anaplastic large cell lymphoma","volume":"182","author":"Lowe E.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10087"},{"key":"e_1_2_13_59_1","first-page":"64","article-title":"Global genetic profiling of a pediatric series of T\u2010cell lymphoblastic lymphoma","volume":"182","author":"Martin\u2010Guerrero I.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.6791"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26363"},{"key":"e_1_2_13_62_1","first-page":"63","article-title":"Glucocorticoids paradoxically induce steroid resistance through a STAT5\u2010mediated survival mechanism in T\u2010cell acute lymphoblastic leukemia\/lymphoma","volume":"182","author":"Meyer L.K.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5827"},{"key":"e_1_2_13_64_1","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1200\/JCO.2016.34.15_suppl.10507","article-title":"Results of the randomized Intergroup trial Inter\u2010B\u2010NHL Ritux 2010 for children and adolescents with high\u2010risk B\u2010cell non\u2010Hodgkin lymphoma (B\u2010NHL) and mature acute leukemia (B\u2010AL): evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen","volume":"34","author":"Minard\u2010Colin V.","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.07.014"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.59"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.4830"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.112"},{"key":"e_1_2_13_69_1","first-page":"17","article-title":"The role of liquid biopsy in non\u2010Hodgkin lymphomas of childhood","volume":"182","author":"Mussolin L.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8161"},{"key":"e_1_2_13_71_1","first-page":"21","article-title":"CD19\/CMV CAR T cells and post CMV vaccine strategies","volume":"182","author":"Nakamura R.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00246-X"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-764209"},{"key":"e_1_2_13_74_1","first-page":"37","article-title":"Ibrutinib significantly inhibited bruton's tyrosine kinase (BTK) phosphorylation, in\u2010vitro proliferation and enhanced overall survival in a preclinical burkitt lymphoma (BL) model","volume":"182","author":"Nayyar G.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa060185"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036673"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14044"},{"key":"e_1_2_13_78_1","first-page":"17","article-title":"Mutational landscape of pediatric\u2010type follicular lymphoma (PTFL)","volume":"182","author":"Quintanilla\u2010Fend L.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_79_1","first-page":"23","article-title":"Early response data for pediatric patients with non\u2010Hodgkin lymphoma treated with CD19 chimeric antigen receptor (CAR) T\u2010cells","volume":"182","author":"Rivers J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.3994"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1701263114"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7203"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-330795"},{"key":"e_1_2_13_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0745"},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.194"},{"key":"e_1_2_13_87_1","first-page":"16","article-title":"Circulating tumor DNA (ctDNA) in B\u2010cell lymphoma","volume":"182","author":"Scherer F.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-703819"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-776278"},{"key":"e_1_2_13_90_1","first-page":"10","article-title":"Promising targets in B cell primary central nervous system lymphoma","volume":"182","author":"Shipp M.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14009"},{"key":"e_1_2_13_92_1","first-page":"10","article-title":"DNA methylone in Burkitt lymphoma","volume":"182","author":"Siebert R.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-18257-5_21"},{"key":"e_1_2_13_94_1","first-page":"31","article-title":"Diagnosis and outcome of extranodal NK\/T\u2010cell lymphoma in children and adolescents: the Japan experience","volume":"182","author":"Suzuki R.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_95_1","first-page":"32","article-title":"Allogeneic versus autologous bone marrow transplantation for NK\/T and non\u2010anaplastic peripheral T cell lymphomas","volume":"182","author":"Termuhlen A.M.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24149"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12460"},{"key":"e_1_2_13_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27407"},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5292"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13958"},{"key":"e_1_2_13_101_1","first-page":"27","article-title":"Primary cutaneous anaplastic large cell lymphoma and other cutaneous T\u2010 cell lymphomas in children and adolescents","volume":"182","author":"Willemze R.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"e_1_2_13_103_1","first-page":"21","article-title":"Hematopoietic stem cell transplantation in relapsed\/refractory NHL","volume":"182","author":"Woessmann W.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8417"},{"key":"e_1_2_13_105_1","first-page":"15","volume":"182","author":"Xavier A.C.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_106_1","first-page":"63","article-title":"Genomic analysis of early T\u2010cell precursor lymphoblastic lymphoma","volume":"182","author":"Xu X.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.1619"},{"key":"e_1_2_13_108_1","first-page":"31","article-title":"Novel treatment and outcome of extranodal NK\/T cell lymphoma, the Beijing experience","volume":"182","author":"Yang J.","year":"2018","journal-title":"British Journal of Haematology"},{"key":"e_1_2_13_109_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002965"},{"key":"e_1_2_13_110_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-405456"},{"key":"e_1_2_13_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.02.008"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15764","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.15764","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T21:25:07Z","timestamp":1694381107000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.15764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/bjh.15764"],"URL":"https:\/\/doi.org\/10.1111\/bjh.15764","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"2019-02-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}